announcement out, page-55

Still hoping we will see a follow up statement giving us more detail on the JDA. Be a bit poor if they didn't.

Need to also take into consideration the AGM corporate presentation slide regarding progress through the year re categories. Cosmetic & skincare was just about to enter prototype vs oral care which was still pre efficacy.

Given that, and with the last 7 months passing we could see some very good results sooner rather than later. (here's hoping they have continued down their merry path of developing a prototype or two). Each brand will be taking ownership of development and progressing at there own pace (budget sign-off will be with the brands). First to market now I think would be the aim.

And as has been discussed before less hurdles and hoops to jump through to get the product up.

With GSK expanding its scope obviously meant the trials were a success (shame they did not comment on that in the quarterly)